Cargando…
Correction: Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis
Autores principales: | Wu, Mei-Yi, Chen, Tzu-Ting, Chen, Ying-Chun, Tarng, Der-Cherng, Wu, Yun-Chun, Lin, Hsien-Ho, Tu, Yu-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459596/ https://www.ncbi.nlm.nih.gov/pubmed/30973944 http://dx.doi.org/10.1371/journal.pone.0215624 |
Ejemplares similares
-
Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis
por: Wu, Mei-Yi, et al.
Publicado: (2017) -
Efficacy and safety of intravenous OPC‐61815 compared with oral tolvaptan in patients with congestive heart failure
por: Sato, Naoki, et al.
Publicado: (2022) -
The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure
por: Otsuka, Tomoyuki, et al.
Publicado: (2013) -
A case report with shock induced by tolvaptan in an elderly patient with congestive heart failure
por: Zhang, Zhi-gang, et al.
Publicado: (2018) -
Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience
por: Park, Gun Ha, et al.
Publicado: (2018)